TMS Alzheimer's treatment showed 44% slowing of disease progression in a 52-week randomized trial, with Sinaptica ...

A little-discussed gene could help the brain contain toxic protein buildup, offering researchers a promising new target.

A secondary analysis shows machine-learning models using routine clinical and cognitive variables achieved moderate-to-good ...

“Patients with early-onset Alzheimer’s are more likely than older patients to present with symptoms unrelated to memory, at least initially,” said co-senior author Renaud La Joie, a professor in ...

As we get older, occasional forgetfulness can be a normal part of aging. However, certain changes in behavior, daily routines ...

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression ...

First oral session reports 52-week efficacy and safety of AR1001, an investigational daily oral therapy designed to ...

New treatments that can slow the progression of Alzheimer's disease could provide significant lifetime benefits to patients and society, with even greater benefits when initiated earlier, according to ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

Leading Alzheimer's researchers Giacomo Koch, Emiliano Santarnecchi and Harald Hampel to examine emerging evidence, biomarkers and therapeutic ...

Is your memory faltering, or are you experiencing early signs of Alzheimer’s? Does your family history mean you are more ...

Signals can be detected in the way people talk years before symptoms of cognitive decline emerge, researchers are finding.